# OnCo record vorasidenib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/vorasidenib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "vorasidenib" ;
  schema:name "Vorasidenib"@en ;
  schema:description "The first targeted therapy for low-grade brain tumours, delaying the need for radiation and chemotherapy by years."@en ;
  schema:url <https://onco.cc/drugs/vorasidenib/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Vorasidenib> ;
  owl:sameAs <http://www.wikidata.org/entity/Q122240747> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vorasidenib> ;
  onco:status "approved" ;
  onco:modality "Small-molecule IDH1/2 inhibitor" ;
  schema:alternateName "Voranigo" ;
  onco:approval "US 2024: Grade 2 IDH-mutant astrocytoma or oligodendroglioma after surgery, age ≥12", "EU 2025: Grade 2 IDH-mutant glioma ≥12 yrs; 17 Sep 2025" ;
  onco:related <https://onco.cc/biomarkers/idh1-r132/>, <https://onco.cc/biomarkers/idh2-mutation/> ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/idh-mutant-astrocytoma/>, <https://onco.cc/cancers/oligodendroglioma/> ;
  onco:technologies <https://onco.cc/technologies/epigenetic-drugs/>, <https://onco.cc/technologies/idh-inhibitors/> ;
  onco:targets <https://onco.cc/targets/idh/> ;
  onco:companies <https://onco.cc/companies/servier/> .